Promising CAR-T Trial Offers Hope for High-Risk Multiple Myeloma Patients
Recent findings from a CAR-T trial suggest potential in preventing smoldering multiple myeloma from progressing to active disease in high-risk individuals.
Browse the full archive, newest first.